🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-05-01
Trial ID
NCT04863079
Treatments Being Tested
The purpose of this study is to determine safety and preliminary efficacy o...
Status
Recruiting
Location
University of California at San Diego Moores Cancer Center
Start Date
2024-04-22
Trial ID
NCT06385080
Treatments Being Tested
Comparing the PK similarity of BAT3306 and Keytruda; in NSCLC participants ...
Status
Recruiting
Location
Union Hospital Tongji Medical College Huazhong University of Science & Technology
Start Date
2025-10-14
Trial ID
NCT07180862
Treatments Being Tested
This study is being done to find out if a new medicine called PF-08634404, ...
Status
Recruiting
Location
Pioneer Research Center
Start Date
2026-01-06
Trial ID
NCT07222566
Treatments Being Tested
This research study is studying Lenvatinib in combination with Pembrolizuma...
Status
Recruiting
Location
Yale University
Start Date
2025-07-18
Trial ID
NCT04645602
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and effic...
Status
Completed
Location
Levine Cancer Institute
Start Date
2017-05-01
Trial ID
NCT03056001
Treatments Being Tested
The primary objective of this study is to demonstrate pharmacokinetic (PK) ...
Status
Active Not Recruiting
Location
Fundacion ARS Medica
Start Date
2024-09-12
Trial ID
NCT06430866
Treatments Being Tested
The purposes of this study are to: 1) assess the safety and tolerability an...
Status
Terminated
Location
University of California San Diego Moores Cancer Center ( Site 0004)
Start Date
2017-09-20
Trial ID
NCT03249792
Treatments Being Tested
This is a study of HB-202/HB-201 alternating 2-vector therapy with pembroli...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06513884
Treatments Being Tested
This study is a single-center, randomized controlled, phase II clinical tri...
Status
Unknown
Location
Multiple Locations
Start Date
2020-03-01
Trial ID
NCT04252365
Treatments Being Tested